chrX-136208564-A-AG
Variant summary
Our verdict is Pathogenic. The variant received 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_001159702.3(FHL1):c.613dupG(p.Asp205GlyfsTer39) variant causes a frameshift change. The variant was absent in control chromosomes in GnomAD project. Variant has been reported in ClinVar as Likely pathogenic (★★). Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
NM_001159702.3 frameshift
Scores
Clinical Significance
Conservation
Publications
- X-linked myopathy with postural muscle atrophyInheritance: XL Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Orphanet, G2P
- myopathy, reducing body, X-linked, early-onset, severeInheritance: XL Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
- reducing body myopathyInheritance: XL Classification: SUPPORTIVE Submitted by: Orphanet
- X-linked Emery-Dreifuss muscular dystrophyInheritance: XL Classification: SUPPORTIVE Submitted by: Orphanet
- X-linked scapuloperoneal muscular dystrophyInheritance: XL Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 18 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_001159702.3. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| FHL1 | NM_001159702.3 | MANE Plus Clinical | c.613dupG | p.Asp205GlyfsTer39 | frameshift | Exon 6 of 8 | NP_001153174.1 | ||
| FHL1 | NM_001159699.2 | MANE Select | c.661dupG | p.Asp221GlyfsTer29 | frameshift | Exon 5 of 6 | NP_001153171.1 | ||
| FHL1 | NM_001440769.1 | c.661dupG | p.Asp221GlyfsTer39 | frameshift | Exon 5 of 7 | NP_001427698.1 |
Ensembl Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| FHL1 | ENST00000394155.8 | TSL:5 MANE Plus Clinical | c.613dupG | p.Asp205GlyfsTer39 | frameshift | Exon 6 of 8 | ENSP00000377710.2 | ||
| FHL1 | ENST00000370683.6 | TSL:1 MANE Select | c.661dupG | p.Asp221GlyfsTer29 | frameshift | Exon 5 of 6 | ENSP00000359717.1 | ||
| FHL1 | ENST00000543669.5 | TSL:1 | c.613dupG | p.Asp205GlyfsTer29 | frameshift | Exon 5 of 6 | ENSP00000443333.1 |
Frequencies
GnomAD3 genomes Cov.: 22
GnomAD4 exome Cov.: 31
GnomAD4 genome Cov.: 22
ClinVar
Submissions by phenotype
X-linked myopathy with postural muscle atrophy Pathogenic:1
This sequence change creates a premature translational stop signal (p.Asp205Glyfs*29) in the FHL1 gene. While this is not anticipated to result in nonsense mediated decay, it is expected to disrupt the last 76 amino acid(s) of the FHL1 protein. This variant is not present in population databases (gnomAD no frequency). This variant has not been reported in the literature in individuals affected with FHL1-related conditions. ClinVar contains an entry for this variant (Variation ID: 537351). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site. This variant disrupts a region of the FHL1 protein in which other variant(s) (p.Cys209Thrfs*50) have been determined to be pathogenic (PMID: 25246303, 26857240; Invitae). This suggests that this is a clinically significant region of the protein, and that variants that disrupt it are likely to be disease-causing. For these reasons, this variant has been classified as Pathogenic.
not provided Pathogenic:1
Reported previously as a likely pathogenic or pathogenic variant in a patient from a cohort of individuals with hypertrophic cardiomyopathy; detailed clinical information and segregation not provided (PMID: 34714385); Frameshift variant predicted to result in abnormal protein length as the last 76 amino acid(s) are replaced with 28 different amino acid(s), and other similar variants have been reported in HGMD; Not observed at significant frequency in large population cohorts (gnomAD); This variant is associated with the following publications: (PMID: 34714385)
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at